Sinopharm Group Co. Ltd.
HKSE: 1099.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Wanyong Lian
- Employees
- 108,217
- Headquarters
- Shanghai, China
- IPO year
- 2009
- Market cap
- HK$57.5B
- Website
- https://www.sinopharmgroup.com.cn
Loading 1099…
Loading profile data…Frequently asked questions about 1099
What does Sinopharm Group Co. Ltd. (1099.HK) do?
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distributi...
Where does 1099.HK trade?
Sinopharm Group Co. Ltd. (1099.HK) trades on the Hong Kong Stock Exchange.
What sector is 1099.HK in?
Sinopharm Group Co. Ltd. (1099.HK) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Sinopharm Group Co. Ltd.?
Wanyong Lian is the chief executive officer of Sinopharm Group Co. Ltd. (1099.HK).
Where is Sinopharm Group Co. Ltd. headquartered?
Sinopharm Group Co. Ltd. is headquartered in China.
Does 1099.HK pay a dividend?
Yes — Sinopharm Group Co. Ltd. (1099.HK) paid a trailing twelve-month dividend of HKD 0.74 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1099.HK go public?
Sinopharm Group Co. Ltd. (1099.HK) completed its initial public offering in 2009.